// App-Quantinova.ai

: Pituitary Coma? Discordant pituitary biochemistry after consumption of a commercially available ‘Sleep Activator’.

Researchers

Presenter

  • Benjamin Phillips

Principal Investigators

  • Mohit Kumar

Medical Centers

  • Wrightington, Wigan & Leigh NHS Foundation Trust, Department of Endocrinology and Diabetes Mellitus, Wigan, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Central Nervous System (CNS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Hypothyroidism

  • Tuberculosis

  • Epilepsy

Biomarkers

  • Cortisol

  • Follicle-stimulating hormone

  • Insulin-like growth factor 1

Drug/Treatment

  • Hydrocortisone

  • Levothyroxine

  • Tetracosactide

  • MD 1003

  • Mecasermin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved